Adactar, Rachel .

HRN: 03-49-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
AMPICILLIN 1GM (VIAL)
05/09/2025
05/11/2025
IVT
2g
Q6
PROM
Waiting Final Action 
05/10/2025
METRONIDAZOLE 500MG (TAB)
05/10/2025
05/17/2025
PO
500 Mg
TID
Thickly Msaf
Waiting Final Action 
05/10/2025
CO-AMOXICLAV 625MG (TAB)
05/10/2025
05/17/2025
PO
625 Mg
BID
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: